The Valley Desk

Clinical trial reportEndocrine-related cancerPublished

Cabozantinib for advanced grade 3 neuroendocrine tumors: subgroup analysis of the phase 3 CABINET trial (Alliance A021602)

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Endocrine-related cancer
Published
Subject terms
Humans; Neuroendocrine Tumors; Anilides; Pyridines; Antineoplastic Agents; Adult; Aged; Middle Aged; Female; Male; Neoplasm Grading; Pancreatic Neuroendocrine Tumor
PubMed ID
41524552
PubMed Central ID
PMC12872296
Added to directory
Source checked

Report a correction or request removal